Molecular mechanisms of microRNA-301a during tumor progression and metastasis

被引:9
|
作者
Shad, Arya Nasimi [1 ]
Fanoodi, Ali [2 ]
Maharati, Amirhosein [1 ]
Akhlaghipour, Iman [1 ]
Moghbeli, Meysam [3 ]
机构
[1] Mashhad Univ Med Sci, Student Res Comm, Fac Med, Mashhad, Iran
[2] Birjand Univ Med Sci, Student Res Comm, Fac Med, Mashhad, Iran
[3] Mashhad Univ Med Sci, Sch Med, Dept Med Genet & Mol Med, Mashhad, Iran
关键词
MicroRNA-301a; Non-invasive; Diagnosis; Cancer; EPITHELIAL-MESENCHYMAL TRANSITION; PROMOTES CELL-PROLIFERATION; PROSTATE-CANCER CELLS; B-REPRESSING FACTOR; FACTOR-KAPPA-B; BREAST-CANCER; TGF-BETA; PANCREATIC-CANCER; ANDROGEN RECEPTOR; DRUG-RESISTANCE;
D O I
10.1016/j.prp.2023.154538
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cancer is known as one of the leading causes of human deaths globally. Late diagnosis is considered as one of the main reasons for the high mortality rate among cancer patients. Therefore, the introduction of early diagnostic tumor markers can improve the efficiency of therapeutic modalities. MicroRNAs (miRNAs) have a key role in regulation of cell proliferation and apoptosis. MiRNAs deregulation has been frequently reported during tumor progressions. Since, miRNAs have a high stability in body fluids; they can be used as the reliable non-invasive tumor markers. Here, we discussed the role of miR-301a during tumor progressions. MiR-301a mainly functions as an oncogene via the modulation of transcription factors, autophagy, epithelial-mesenchymal transition (EMT), and signaling pathways. This review paves the way to suggest miR-301a as a non-invasive marker for the early tumor diagnosis. MiR-301a can also be suggested as an effective target in cancer therapy.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Upregulated microRNA-301a in osteosarcoma promotes tumor progression by targeting CDC14A
    Ni, Z.
    Shang, X. F.
    Wang, Y. F.
    Sun, Y. J.
    Fu, D. J.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2016, 15 (02)
  • [2] MicroRNA-301a inhibits the progression of osteosarcoma by regulating DEC2
    Wu, Hao
    Yu, Zhongjie
    Chen, Qi
    Li, Dong
    Chen, Wei
    [J]. JOURNAL OF BUON, 2020, 25 (02): : 1013 - 1021
  • [3] Molecular mechanisms of microRNA-216a during tumor progression
    Hamidi, Amir Abbas
    Taghehchian, Negin
    Zangouei, Amir Sadra
    Akhlaghipour, Iman
    Maharati, Amirhosein
    Basirat, Zahra
    Moghbeli, Meysam
    [J]. CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [4] Molecular mechanisms of microRNA-216a during tumor progression
    Amir Abbas Hamidi
    Negin Taghehchian
    Amir Sadra Zangouei
    Iman Akhlaghipour
    Amirhosein Maharati
    Zahra Basirat
    Meysam Moghbeli
    [J]. Cancer Cell International, 23
  • [5] Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling
    Ma, Fei
    Zhang, Jianguo
    Zhong, Lei
    Wang, Lei
    Liu, Yansong
    Wang, Yimin
    Peng, Lin
    Guo, Baoliang
    [J]. GENE, 2014, 535 (02) : 191 - 197
  • [6] Elucidating molecular mechanisms linking microRNA-206 loss to tumor progression and metastasis
    Watt, Kathleen D.
    Truesdell, Peter
    Craig, Andrew W.
    [J]. CANCER RESEARCH, 2015, 75
  • [7] MOLECULAR MECHANISMS OF INVASION AND METASTASIS DURING MOUSE SKIN TUMOR PROGRESSION
    PORTELLA, G
    LIDDELL, J
    CROMBIE, R
    HADDOW, S
    CLARKE, M
    STOLER, AB
    BALMAIN, A
    [J]. INVASION & METASTASIS, 1994, 14 (1-6): : 7 - 16
  • [8] Role of microRNA-505 during tumor progression and metastasis
    Maharati, Amirhosein
    Moghbeli, Meysam
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2024, 258
  • [9] Glycine confers neuroprotection through microRNA-301a/PTEN signaling
    Chen, Juan
    Zhuang, Yang
    Zhang, Zhi-Feng
    Wang, Shu
    Jin, Ping
    He, Chunjiang
    Hu, Peng-Chao
    Wang, Ze-Fen
    Li, Zhi-Qiang
    Xia, Guang-Ming
    Li, Gang
    Wang, Yuan
    Wan, Qi
    [J]. MOLECULAR BRAIN, 2016, 9
  • [10] MicroRNA-301a/ZNRF3/wnt/β-catenin signal regulatory crosstalk mediates glioma progression
    Sun, Jikui
    Ma, Quanfeng
    Shu, Chang
    Xiong, Jinbiao
    Li, Banban
    Wu, Jingchao
    Zhang, Shusheng
    Li, Jialin
    Liu, Jun
    Wang, Jinhuan
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 58 (01) : 45 - 56